| 000 | 01506 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513213156.0 | ||
| 264 | 0 | _c20000713 | |
| 008 | 200007s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diabetes.49.3.340 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLing, Z | |
| 245 | 0 | 0 |
_aInterleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. _h[electronic resource] |
| 260 |
_bDiabetes _cMar 2000 |
||
| 300 |
_a340-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlloxan _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xphysiology |
| 650 | 0 | 4 |
_aCytokines _xphysiology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNecrosis |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
| 650 | 0 | 4 | _aOsmolar Concentration |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aProteins _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aStreptozocin _xpharmacology |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 700 | 1 | _aVan de Casteele, M | |
| 700 | 1 | _aEizirik, D L | |
| 700 | 1 | _aPipeleers, D G | |
| 773 | 0 |
_tDiabetes _gvol. 49 _gno. 3 _gp. 340-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diabetes.49.3.340 _zAvailable from publisher's website |
| 999 |
_c10819752 _d10819752 |
||